The Biomedrex team includes a combination of entrepreneurs and scientists, both in leadership and advisory roles. The company has both a business advisory board and a scientific advisory board with over 30 years of experience. Amongst these are the first drug specifically targeting HIV, and a cancer drug taken from discovery to its current phase III trial.


Corinne Kay, PhD, Chief Research Officer
Antiviral drug discovery
HIV-expert


Dr. Jan Scicinski, PhD, Regulatory
Antiviral drug discovery
Influenza-expert


Marjo Puumalainen, PhD, Chief Scientific Officer
Antiviral drug discovery
Screening of antivirals
Assay development


Fredrik Wallgren, Chief Financing Officer
Economy
Administration of large companies


Martin Ekenberg, Chief Technology Officer
System architecture
Artificial intelligence
Cloud computing


Theodor Pramer, Founder and CEO
Serial entrepreneur
Inventor


Gözde Güçlüler, PhD, Research scientist
Animal models
Drug delivery


Laura Sardon Puig , PhD, Research scientist
Human cell models
Transfection
Cellular imaging


Ani Azatyan, PhD, Research scientist
RNA specialist
Gene sequencing
Bioinformatics


Richard Tubb, Scientific advisor
Longest serving US White House physician


Ajay Kori, Advisor
Serial entrepreneur from Harvard


Josh Deckard, Advisor
Successfull early stage investor

Backers & incubators

Almi

Startup Stockholm

VINNOVA

NVIDIA inception program

Amazon AWS activate

Nyföretagarcentrum.